ANGO
$10.71
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.
Recent News
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
ANGO stock is buoyed by strong fiscal Q2 results, surging NanoKnife adoption in prostate cancer and broad Med Tech growth supporting margins.
AngioDynamics CEO Details Portfolio Shift as Auryon, AlphaVac and NanoKnife Fuel Growth at Conference
AngioDynamics (NASDAQ:ANGO) CEO Jim Clemmer said the company has spent the last several years reshaping its portfolio and operating model, moving away from slower-growth, more commodity-oriented markets and toward what he described as larger, faster-growing med-tech categories where outcomes can be
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
Parsons delivers technology-driven solutions for defense, intelligence, and critical infrastructure clients across North America and beyond.
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
TransMedics posts 200% EPS surge and 32% revenue growth in Q4, tops estimates and guides for up to 25% sales growth in 2026.
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth
DXCM beats Q4 EPS estimates, posts 13% revenue growth and reiterates 2026 guidance as G7 15 Day rollout and margin gains drive momentum.